PointState Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-57,836
Closed -$10.3M 60
2022
Q2
$10.3M Buy
+57,836
New +$10.3M 0.26% 36
2021
Q2
Sell
-35,000
Closed -$5.75M 155
2021
Q1
$5.75M Sell
35,000
-8,200
-19% -$1.33M 0.11% 96
2020
Q4
$6.8M Sell
43,200
-127,785
-75% -$18.9M 0.13% 83
2020
Q3
$25.5M Buy
170,985
+19,733
+13% +$2.92M 0.67% 33
2020
Q2
$21.3M Buy
+151,252
New +$22M 0.64% 35
2019
Q4
Sell
-11,700
Closed -$1.51M 124
2019
Q3
$1.51M Buy
+11,700
New +$1.54M 0.04% 88

Other funds holding JNJ

PointState Capital's JNJ Position: Q3 2022 in Review

PointState Capital sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 57,836 shares — an estimated $10.3M sold.

PointState Capital first reported a position in JNJ in Q3 2019 and held it in 6 quarters. The position peaked at $25.5M in Q3 2020. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • PointState Capital reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • PointState Capital sold 57,836 Johnson & Johnson shares in Q3 2022, an estimated $10.3M.
  • PointState Capital first reported a position in Johnson & Johnson in Q3 2019 and held it in 6 quarters.
  • PointState Capital's Johnson & Johnson position peaked at $25.5M in Q3 2020.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on PointState Capital's 13F filing for Q3 2022, filed 10 Nov 2022.